138 related articles for article (PubMed ID: 36072008)
1. Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer.
Luo X; Tai J; Zhao Y; Zhao P; Sun D; Wang L
Oncol Lett; 2022 Oct; 24(4):348. PubMed ID: 36072008
[TBL] [Abstract][Full Text] [Related]
2. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients.
Gu L; Yao Y; Chen Z
Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406
[TBL] [Abstract][Full Text] [Related]
3. Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients.
Wan X; Hong Z; Mao Y; Di W
Transl Cancer Res; 2020 Feb; 9(2):726-734. PubMed ID: 35117418
[TBL] [Abstract][Full Text] [Related]
4. A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer.
Wang D; Luo Y; Guo Y; Li G; Li F
Int J Biol Markers; 2020 Jun; 35(2):74-81. PubMed ID: 32339056
[TBL] [Abstract][Full Text] [Related]
5. The role of CXCL chemokine family in the development and progression of gastric cancer.
Chen X; Chen R; Jin R; Huang Z
Int J Clin Exp Pathol; 2020; 13(3):484-492. PubMed ID: 32269686
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma.
Li Y; Wu T; Gong S; Zhou H; Yu L; Liang M; Shi R; Wu Z; Zhang J; Li S
Front Oncol; 2020; 10():570736. PubMed ID: 33489879
[TBL] [Abstract][Full Text] [Related]
7. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
[TBL] [Abstract][Full Text] [Related]
8. A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia.
Hao X; Gu M; Sun J; Cong L
J Clin Lab Anal; 2020 Feb; 34(2):e23052. PubMed ID: 31617252
[TBL] [Abstract][Full Text] [Related]
9. Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
Zeng J; Yang X; Cheng L; Liu R; Lei Y; Dong D; Li F; Lau QC; Deng L; Nice EC; Xie K; Huang C
J Transl Med; 2013 Jan; 11():6. PubMed ID: 23294544
[TBL] [Abstract][Full Text] [Related]
10. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
11. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer.
Li X; Zhong Q; Luo D; Du Q; Liu W
PLoS One; 2019; 14(4):e0214611. PubMed ID: 30973890
[TBL] [Abstract][Full Text] [Related]
13. Complementary action of CXCL1 and CXCL8 in pathogenesis of gastric carcinoma.
Chen X; Jin R; Chen R; Huang Z
Int J Clin Exp Pathol; 2018; 11(2):1036-1045. PubMed ID: 31938199
[TBL] [Abstract][Full Text] [Related]
14. SOX30 Overexpression Reflects Tumor Invasive Degree, Lymph Node Metastasis and Predicts Better Survival in Colorectal Cancer Patients: A Long-Term Follow-Up Cohort Study.
Li C; Li P; Yu L; Sun Q; Gu B; Sun Y; Sun L
Front Surg; 2022; 9():898952. PubMed ID: 35836594
[TBL] [Abstract][Full Text] [Related]
15. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer.
Qi XW; Xia SH; Yin Y; Jin LF; Pu Y; Hua D; Wu HR
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1916-24. PubMed ID: 25010623
[TBL] [Abstract][Full Text] [Related]
16. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways.
Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L
Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353
[TBL] [Abstract][Full Text] [Related]
17. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
[TBL] [Abstract][Full Text] [Related]
18. A Novel Model Based on CXCL8-Derived Radiomics for Prognosis Prediction in Colorectal Cancer.
Chu Y; Li J; Zeng Z; Huang B; Zhao J; Liu Q; Wu H; Fu J; Zhang Y; Zhang Y; Cai J; Zeng F
Front Oncol; 2020; 10():575422. PubMed ID: 33178604
[No Abstract] [Full Text] [Related]
19. CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.
Wei Y; Lin C; Li H; Xu Z; Wang J; Li R; Liu H; Zhang H; He H; Xu J
Cancer Immunol Immunother; 2018 Feb; 67(2):261-269. PubMed ID: 29085997
[TBL] [Abstract][Full Text] [Related]
20. Potential of C-X-C motif chemokine ligand 1/8/10/12 as diagnostic and prognostic biomarkers in idiopathic pulmonary arterial hypertension.
Li Z; Jiang J; Gao S
Clin Respir J; 2021 Dec; 15(12):1302-1309. PubMed ID: 34260815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
